Bety.com Introduces Blockchain-Powered Transparency and Fairness to Online Gaming
Victoria, Seychelles, December 19th, 2024, Chainwire BETY.com is enhancing the online gaming and betting landscape by integrating blockchain technology and hash algorithms to...
Read More
National average money market account rates for December 2024
Get the latest rates on top-yielding money market accounts.
Read More
Analysts unveils stock market game plans after Fed-driven tumble
Market veterans break down the story behind the market's recent tumble.
Read More
It's Time to Buy the Dip on Carvana Stock
Carvana stock could rocket back toward three-year highs, if past is precedent
Read More
Cintas Stock Sinks on Drop in Uniform Direct Sales
Cintas shares tumbled Thursday as the provider of uniforms and other business supplies reported a decline in direct sales of its uniforms and warned about pricing.
Read More
Stock market outlook for 2025: 4 experts weigh in
The year ahead promises to be interesting for investors. We explore what experts say about the competing dynamics in 2025 and their impact on different areas of the stock market.
Read More
Resale’s Growth Outpaces Broader Apparel and Footwear Market
New research shows that the resale sector is accelerating fast, and has overtaken sales in the broader apparel, accessories and footwear categories.
Read More
Soho House revives talks to quit the stock market in £1.4bn deal
Soho House’s billionaire chairman has revived efforts to take the private members’ club off the US stock market, backing a near $1.8bn (£1.4bn) buyout bid.
Read More
Why Is Vertex Pharmaceuticals Stock Trading Lower On Thursday After Back Pain Trial Data?
On Thursday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR), a disorder that causes pain in the lower back and hip that radiates down the back of the thigh into the leg. The study met its primary endpoint with a statistically significant and clinically meaningful reduction in pain on the numeric pain rating scale (NPRS). The suzetrigine arm showed a statistically significant and clinically mean
Read More
Micron Stock Plunges After Company Cuts Outlook, Analysts Raise Concerns
Micron Technology shares tanked Thursday after the chipmaker warned about near-term demand issues.
Read More
Massive 400 Billion SHIB From Early Whale Stuns Major US Exchange
U.Today - According to analytics X account @Spotonchain, earlier today, two staggering amounts of Shiba Inu meme coins were sold. This has happened as the second most popular in...
Read More
Vertex’s stock hurt after non-opioid pain drug shows benefit similar to placebo
Vertex said the Phase II trial met its primary endpoint, however there was only a minor difference to placebo.
Read More
Top Stock Movers Now: Darden Restaurants, CarMax, Micron Technology, and More
Major U.S. indexes rallied at midday Thursday, rebounding from Wednesday's selloff as a report showed the U.S. economy expanded more than anticipated in the third quarter.
Read More
Jim Cramer Warns Of 'Incredible Panic' As Jerome Powell's Hawkish Outlook Send Stocks Into Free Fall: 'People Throwing Away Good And Bad'
The U.S. stock market experienced a severe selloff Wednesday after Federal Reserve Chair Jerome Powell‘s comments triggered what CNBC’s Jim Cramer described as “incredible panic” in the markets. What Happened: “People throwing away good and bad. Typical index fund behavior,” Cramer wrote on X, specifically highlighting concerns about small-cap stocks’ performance. “And all of those people who loved the Small Caps (the Russell 2000?) now what??” Don’t Miss: Warren Buffett once said, "If you don't
Read More
Wall Street Pins Hopes On Friday's Crucial Fed Inflation Report: Miracle Needed To Shift Narrative
If markets hope to recover from the sharp sell-off triggered by the Federal Reserve’s December meeting, Friday's release of the Personal Consumption Expenditure price index — widely regarded as the Fed’s preferred inflation measure — will play a crucial role. Unfortunately for investors, the outlook is far from reassuring. Scheduled for release at 8:30 a.m. ET Friday, economists expect the PCE price index to climb to 2.5% year-over-year in November 2024, up from 2.3% in October. This would mark
Read More